These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21679106)

  • 1. Platelet kinetics after slow versus standard transfusions: a pilot study.
    Habibi A; Esfandbod M; Ghafari MH; Khashayar P; Najafi A; Moharari RS
    Ups J Med Sci; 2011 Aug; 116(3):212-5. PubMed ID: 21679106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study.
    Zisk JL; Mackley A; Clearly G; Chang E; Christensen RD; Paul DA
    Platelets; 2014; 25(7):513-6. PubMed ID: 24224920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
    Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
    van Rhenen D; Gulliksson H; Cazenave JP; Pamphilon D; Ljungman P; Klüter H; Vermeij H; Kappers-Klunne M; de Greef G; Laforet M; Lioure B; Davis K; Marblie S; Mayaudon V; Flament J; Conlan M; Lin L; Metzel P; Buchholz D; Corash L;
    Blood; 2003 Mar; 101(6):2426-33. PubMed ID: 12456508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
    Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
    Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined plasma exchange and platelet transfusion in immune-mediated thrombocytopenic emergencies.
    Finn L; Tun H
    Transfus Apher Sci; 2013 Dec; 49(3):661-4. PubMed ID: 23856529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia.
    Baron E; Charpentier J; François A; Ben Hadj Amor H; Habr B; Cariou A; Chiche JD; Mira JP; Jamme M; Pène F
    Transfusion; 2020 Feb; 60(2):275-284. PubMed ID: 31724828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
    Tripodi A; Primignani M; Chantarangkul V; Lemma L; Jovani M; Rebulla P; Mannucci PM
    Liver Int; 2013 Mar; 33(3):362-7. PubMed ID: 23231699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
    Estcourt LJ; Desborough M; Hopewell S; Doree C; Stanworth SJ
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011771. PubMed ID: 26627708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.
    Warner MA; Chandran A; Frank RD; Kor DJ
    Anesth Analg; 2019 Feb; 128(2):288-295. PubMed ID: 29293185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.
    Simonsen AC; Johansson PI; Conlan MG; Jacquet M; Lin JS; Junge K; Lin L; Sørensen H; Borregaard N; Flament J
    Transfusion; 2006 Mar; 46(3):424-33. PubMed ID: 16533286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
    Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
    Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Transfusions in the Neonatal Intensive Care Unit.
    Sparger K; Deschmann E; Sola-Visner M
    Clin Perinatol; 2015 Sep; 42(3):613-23. PubMed ID: 26250921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.